Kaken Pharmaceutical Co's total assets for Q3 2025 were ¥193.42B, an increase of 3.37% from the previous quarter. KKPCF total liabilities were ¥38.16B for the fiscal quarter, a 16.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.